News Focus
News Focus
icon url

jessellivermore

04/01/15 7:18 AM

#46465 RE: steve2014 #46451

steve..

I am not a licensed financial advisor. Take this information for what it is worth.

Are you an investor? If so, follow the fundamentals. In AMRN's situation this means figuring the potential market for their drug...easily over 35 million users, the difficulties in supplying that potential. The possibility that an alternate solution or drug could derail them (not very likely IMO)..the possibility the drug doesn't work (very unlikely IMO) and possible "Black Swan" event.

Are you a trader (long term or short term)? Follow the technicals. Read LeFevre's book "Reminiscence of a stock trader" which details the market experiences of J. L. Livermore..A must for any serious market player. Then read Livermore's book, "How to trade in stocks" great advice on when to buy and sell based on the stock's behavior..

Then you need to get lucky..

":>) JL